Medpace Holdings Inc vs abrdn Physical Palladium Shares ETF — how do they compare? Medpace Holdings Inc trades at $530 (market cap $15.08B), while abrdn Physical Palladium Shares ETF trades at $23.28. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | PALL | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $620.59 | $37.18 |
52-Week Low | $308.88 | $19.96 |
Enterprise Value | $14.55B | — |
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →